Autopsy report · NCT02120976
Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of JTT-252
Cause of deathNo reason given
Life of this trial
- Ran for about 11 months before it stopped.
- 85 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Akros Pharma Inc.
- Sponsor type
- Industry
- Conditions
- Diabetes Mellitus
- Interventions
- JTT-252 or Placebo; JTT-252
- Participants
- 85
- Sites
- 2
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.